Back
51
Day Range
$155.67
$158.10
52-Week Range
$127.59
$187.35
Volume
1,652,406
50D / 200D Avg
$166.77
/
$151.59
Prev Close
$154.13
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 33.7 | 0.4 |
| P/B | 2.2 | 2.9 |
| ROE % | 6.5 | 3.8 |
| Net Margin % | 7.7 | 3.9 |
| Rev Growth 5Y % | 3.4 | 10.0 |
| D/E | 0.8 | 0.2 |
Analyst Price Target
Hold
$193.80
+24.0%
Low: $170.00
High: $215.00
Forward P/E
12.5
Forward EPS
$12.52
EPS Growth (est.)
+0.0%
Est. Revenue
19 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$16.91
$16.75 – $17.26
|
22 B | 1 |
| FY2029 |
$15.63
$15.48 – $15.95
|
21 B | 1 |
| FY2028 |
$14.29
$14.16 – $14.59
|
20 B | 1 |
Key Takeaways
Revenue grew 3.37% annually over 5 years — modest growth
Generating 2.67B in free cash flow
P/E of 33.73 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.86%
Cash machine — converts 159.12% of earnings into free cash flow
Capital efficient — spends only 3.48% of revenue on capex
Growth
Revenue Growth (5Y)
3.37%
Revenue (1Y)8.23%
Earnings (1Y)-1.58%
FCF Growth (3Y)12.36%
Quality
Return on Equity
6.54%
ROIC4.34%
Net Margin7.68%
Op. Margin11.80%
Safety
Debt / Equity
0.76
Current Ratio1.11
Interest Coverage4.21
Valuation
P/E Ratio
33.73
P/B Ratio2.23
EV/EBITDA29.07
Dividend Yield0.04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.23% | Revenue Growth (3Y) | 6.18% |
| Earnings Growth (1Y) | -1.58% | Earnings Growth (3Y) | 6.34% |
| Revenue Growth (5Y) | 3.37% | Earnings Growth (5Y) | -5.36% |
| Profitability | |||
| Revenue (TTM) | 21.84B | Net Income (TTM) | 1.68B |
| ROE | 6.54% | ROA | 3.03% |
| Gross Margin | 45.44% | Operating Margin | 11.80% |
| Net Margin | 7.68% | Free Cash Flow (TTM) | 2.67B |
| ROIC | 4.34% | FCF Growth (3Y) | 12.36% |
| Safety | |||
| Debt / Equity | 0.76 | Current Ratio | 1.11 |
| Interest Coverage | 4.21 | Dividend Yield | 0.04% |
| Valuation | |||
| P/E Ratio | 33.73 | P/B Ratio | 2.23 |
| P/S Ratio | 2.59 | PEG Ratio | -29.05 |
| EV/EBITDA | 29.07 | Dividend Yield | 0.04% |
| Market Cap | 56.60B | Enterprise Value | 74.93B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 21.84B | 20.18B | 19.37B | 18.87B | 19.13B |
| Net Income | 1.68B | 1.71B | 1.48B | 1.78B | 2.09B |
| EPS (Diluted) | 5.83 | 5.86 | 4.94 | 5.88 | 6.85 |
| Gross Profit | 9.92B | 9.13B | 8.17B | 8.48B | 8.63B |
| Operating Income | 2.58B | 2.40B | 2.11B | 2.28B | 2.25B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 55.33B | 57.29B | 52.78B | 52.93B | 53.88B |
| Total Liabilities | 29.94B | 31.40B | 26.98B | 27.65B | 30.20B |
| Shareholders' Equity | 25.39B | 25.89B | 25.80B | 25.28B | 23.68B |
| Total Debt | 19.18B | 21.59B | 16.82B | 16.95B | 18.42B |
| Cash & Equivalents | 851.00M | 1.86B | 1.42B | 1.16B | 2.39B |
| Current Assets | 9.26B | 10.47B | 8.68B | 8.14B | 8.84B |
| Current Liabilities | 8.31B | 8.96B | 6.64B | 7.81B | 6.63B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#373 of 1024
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026